Journals / Cerrahpaşa Tıp Dergisi / 2007 / Cilt: 38 - Sayı: 3

Diagnosis of acute pulmonary embolism

Akut pulmoner embolide tanı

Pages
118–126
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite vigorous debate for optimal therapeutic approach, the majority of deaths from PE are a result of prophylactic oversight or diagnostic error.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute pulmonary embolism represents a potentially fatal disease.
📊
Key Findings & Data:The disease presents mostly with silent or nonspecific symptoms.
💡
Conclusion & Impact:Despite vigorous debate for optimal therapeutic approach, the majority of deaths from PE are a result of prophylactic oversight or diagnostic error.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute pulmonary embolism represents a potentially fatal disease. The disease presents mostly with silent or nonspecific symptoms. A number of fundamental questions continue to exist regarding the pathogenesis, clinical presentation and diagnosis. Although there is a wide range of diagnostic techniques, pulmonary embolism still remains as a diagnostic challenge for the pulmonary physicia. Therefore, in a patient with suspected pulmonary embolism, understanding the pathogenesis and clinical presentation can result in a more precise diagnosis without delay. Despite vigorous debate for optimal therapeutic approach, the majority of deaths from PE are a result of prophylactic oversight or diagnostic error.

Özet

Akut pulmoner emboli potansiyel açıdan ciddi ölüm riski taşıyan bir hastalıktır. Hastalık çoğunlukla sessiz ya da nonspesifik semptomlarla seyreder. Patogenez, klinik yaklaşım ve tanı yönünden bazı temel sorular henüz açıklığa kavuşmamıştır. Günümüzde birçok tanı yöntemi bulunmasına rağmen pulmoner emboli halen klinisyen için önemli bir tanı problemi teşkil etmektedir. Bu nedenle, pulmoner emboli şüphesi olan bir hastada patogenez ve kliniğin iyi anlaşılması gecikme olmaksızın kesin tanıya ulaşılmasını sağlayacaktır. Tedavi yaklaşımlarında birçok tartışma buunmasına rağmen, hastaların çoğu yetersiz profilaksi veya tanı hatası nedeniyle kaybedilmektedir.

🔖

Cite This Article

TETİKKURT, C. (2022). Diagnosis of acute pulmonary embolism. Cerrahpaşa Tıp Dergisi, Cilt: 38 - Sayı: 3, 118–126. https://ajindex.com/articles/473334

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: 4-8
  2. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, Schwartz JS, Thompson BT, Popovich J Jr, Hobbins TE ve ark. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-1245
  3. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’ Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25 –year population based study. Arch Intern Med 1998; 158: 585-593
  4. Douketis JD, Keaton C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279:458-462
  5. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’ Fallon WM, Melton LJ. Predictors of survival after deep venous thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-453
  6. Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ 3rd. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002 10; 162: 1245-1248
  7. Macik BG, Ortel T.Clinical and laboratory evaluation of the hypercoagulable states. Clin Chest Med 1995; 16: 375-389
  8. Fedullo PF, Morris TA. Pulmonary thromboembolim. Mason RJ, Murray FJ, Broaddus VC, Nadel JA, editör. Textbook of Respiratory Medicine. Philadelphia, Elsevier Saunders. 2005; 1425-1458
  9. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-645
  10. Donati MB. Cancer and thrombosis. Hemostasis 1994; 24: 128-131
  11. Merli GJ. Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery. Med Clin North Am 1993; 77: 397-411
  12. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism: Chest 2001; 119: 132-175
  13. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Haematologica 1999; 84: 437-445
  14. Joffe HV, Goldhaber SZ. Hypercoagulable states and other risk factors for venous thromboembolism. Dalen EJ, editör. Venous Thromboembolism. New York, Marcel Dekker. 2003, 11-21
  15. Heit JA. Risk factors for venous thromboembolism. Tapson VF, editör. Venous thromboembolism. Clin Chest Med 2003; 24: 1-12
  16. Greaves M. Antiphospholilid antibodies and thrombosis. Lancet 1999; 353: 1